ArrayExpress Uploader0humanadenocarcinomatumor patientnodule siteadenocarcinomatumor patientcontralateral siteadenocarcinomatumor patientnodule siteadenocarcinomatumor patientcontralateral siteadenocarcinomatumor patientnodule siteadenocarcinomatumor patientcontralateral siteadenocarcinomatumor patientnodule siteadenocarcinomatumor patientcontralateral siteadenocarcinomatumor patientnodule siteadenocarcinomatumor patientcontralateral sitesquamous cell carcinomatumor patientnodule sitesquamous cell carcinomatumor patientcontralateral sitesquamous cell carcinomatumor patientnodule sitesquamous cell carcinomatumor patientcontralateral sitesquamous cell carcinomatumor patientnodule sitesquamous cell carcinomatumor patientcontralateral sitesquamous cell carcinomatumor patientnodule sitesquamous cell carcinomatumor patientcontralateral sitesquamous cell carcinomatumor patientnodule sitesquamous cell carcinomatumor patientcontralateral sitebenign diagnosiscontrol patientnodule sitebenign diagnosiscontrol patientcontralateral sitebenign diagnosiscontrol patientnodule sitebenign diagnosiscontrol patientcontralateral sitebenign diagnosiscontrol patientnodule sitebenign diagnosiscontrol patientcontralateral sitebenign diagnosiscontrol patientnodule sitebenign diagnosiscontrol patientcontralateral sitebenign diagnosiscontrol patientnodule sitebenign diagnosiscontrol patientcontralateral site3977arrayexpress_sid4We investigated whether biomarker analysis in endobronchial epithelial lining fluid (ELF) collected by bronchoscopic microsampling may be...E-GEOD-27489/profile/8773/arrayexpressuploader330diseasensclcDec.12, 2014Falsescreening-study-to-identify-diagnostic-markers-forE-GEOD-27489_A-AFFY-44SCREENING STUDY TO IDENTIFY DIAGNOSTIC MARKERS FOR LUNG CANCER IN ENDOBRONCHIAL LINING FLUIDSep.15, 2014We investigated whether biomarker analysis in endobronchial epithelial lining fluid (ELF) collected by bronchoscopic microsampling may be useful for a definitive preoperative diagnosis. Therefore we compared ELF samples close to nodule and from the contralateral site from patients with malignant or benign diagnosis. ELF samples have been derived from early stage NSCLC patients and controls. LIMMA analysis was performed to identify differentially expressed genes associated to a malignant diagnosis. keywords: disease subtype analysishttp://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-27489http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-27489/samples/